StockData
Curis Inc logo

Curis Inc (CRIS) stock

CRISNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$0.45−0.13 (-22.18%)

Close on Nov 13, 2026Market cap $930.08KP/E –Yield –

Curis enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Curis's enterprise value was -$3.95M on Nov 11, 2026, against $15.30M a year earlier. Over the last 5 years it ranged from -$56.40M to $286.26M, with a median of $3.56M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$3.95M-137.9%
2025Dec 31, 2025$10.42M–
2024Dec 31, 2024-$2.48M-137.9%
2023Dec 29, 2023$6.54M–
2022Dec 30, 2022-$45.68M-116.0%
2021Dec 31, 2021$286.26M-35.1%
2020Dec 31, 2020$441.28M+1451.3%
2019Dec 31, 2019$28.44M-2.5%
2018Dec 31, 2018$29.19M-67.0%
2017Dec 29, 2017$88.46M-77.8%
2016Dec 30, 2016$398.73M+30.4%
2015Dec 31, 2015$305.68M+195.4%
2014Dec 31, 2014$103.47M-49.4%
2013Dec 31, 2013$204.61M-12.2%
2012Dec 31, 2012$233.09M-29.4%
2011Dec 30, 2011$330.02M–

More Curis figures

See a number that looks wrong?